226 related articles for article (PubMed ID: 11583066)
1. Glatiramer acetate in the treatment of multiple sclerosis.
Sela M; Teitelbaum D
Expert Opin Pharmacother; 2001 Jul; 2(7):1149-65. PubMed ID: 11583066
[TBL] [Abstract][Full Text] [Related]
2. Copolymer 1: from basic research to clinical application.
Teitelbaum D; Arnon R; Sela M
Cell Mol Life Sci; 1997 Jan; 53(1):24-8. PubMed ID: 9117994
[TBL] [Abstract][Full Text] [Related]
3. Glatiramer acetate (Copaxone) therapy for multiple sclerosis.
Dhib-Jalbut S
Pharmacol Ther; 2003 May; 98(2):245-55. PubMed ID: 12725872
[TBL] [Abstract][Full Text] [Related]
4. Risk-benefit assessment of glatiramer acetate in multiple sclerosis.
Ziemssen T; Neuhaus O; Hohlfeld R
Drug Saf; 2001; 24(13):979-90. PubMed ID: 11735654
[TBL] [Abstract][Full Text] [Related]
5. Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.
Carter NJ; Keating GM
Drugs; 2010 Aug; 70(12):1545-77. PubMed ID: 20687620
[TBL] [Abstract][Full Text] [Related]
6. Recent insights into the mechanism of action of glatiramer acetate.
Kala M; Miravalle A; Vollmer T
J Neuroimmunol; 2011 Jun; 235(1-2):9-17. PubMed ID: 21402415
[TBL] [Abstract][Full Text] [Related]
7. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
Duda PW; Schmied MC; Cook SL; Krieger JI; Hafler DA
J Clin Invest; 2000 Apr; 105(7):967-76. PubMed ID: 10749576
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis.
Dhib-Jalbut S
Neurology; 2002 Apr; 58(8 Suppl 4):S3-9. PubMed ID: 11971121
[TBL] [Abstract][Full Text] [Related]
9. Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis.
Simpson D; Noble S; Perry C
CNS Drugs; 2002; 16(12):825-50. PubMed ID: 12421116
[TBL] [Abstract][Full Text] [Related]
10. Therapy with glatiramer acetate for multiple sclerosis.
Munari L; Lovati R; Boiko A
Cochrane Database Syst Rev; 2004; (1):CD004678. PubMed ID: 14974077
[TBL] [Abstract][Full Text] [Related]
11. United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Multiple Sclerosis Study Group and the MRI Analysis Center.
Wolinsky JS; Narayana PA; Johnson KP;
Mult Scler; 2001 Feb; 7(1):33-41. PubMed ID: 11321192
[TBL] [Abstract][Full Text] [Related]
12. Glatiramer acetate for multiple sclerosis.
La Mantia L; Munari LM; Lovati R
Cochrane Database Syst Rev; 2010 May; (5):CD004678. PubMed ID: 20464733
[TBL] [Abstract][Full Text] [Related]
13. Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action.
Lalive PH; Neuhaus O; Benkhoucha M; Burger D; Hohlfeld R; Zamvil SS; Weber MS
CNS Drugs; 2011 May; 25(5):401-14. PubMed ID: 21476611
[TBL] [Abstract][Full Text] [Related]
14. Specific vaccines against autoimmune diseases.
Sela M
C R Acad Sci III; 1999 Nov; 322(11):933-8. PubMed ID: 10646086
[TBL] [Abstract][Full Text] [Related]
15. The use of glatiramer acetate in the treatment of multiple sclerosis.
Wolinsky JS
Adv Neurol; 2006; 98():273-92. PubMed ID: 16400839
[TBL] [Abstract][Full Text] [Related]
16. Cop 1 as a candidate drug for multiple sclerosis.
Teitelbaum D; Arnon R; Sela M
J Neural Transm Suppl; 1997; 49():85-91. PubMed ID: 9266417
[TBL] [Abstract][Full Text] [Related]
17. The distribution of the magnetic resonance imaging response to glatiramer acetate in multiple sclerosis.
Sormani MP; Bruzzi P; Comi G; Filippi M
Mult Scler; 2005 Aug; 11(4):447-9. PubMed ID: 16042228
[TBL] [Abstract][Full Text] [Related]
18. Spotlight on glatiramer acetate in relapsing-remitting multiple sclerosis.
Simpson D; Noble S; Perry C
BioDrugs; 2003; 17(3):207-10. PubMed ID: 12749757
[TBL] [Abstract][Full Text] [Related]
19. Glatiramer acetate: a review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis.
Scott LJ
CNS Drugs; 2013 Nov; 27(11):971-88. PubMed ID: 24129744
[TBL] [Abstract][Full Text] [Related]
20. Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial.
Cohen J; Belova A; Selmaj K; Wolf C; Sormani MP; OberyƩ J; van den Tweel E; Mulder R; Koper N; Voortman G; Barkhof F;
JAMA Neurol; 2015 Dec; 72(12):1433-41. PubMed ID: 26458034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]